2 unknown. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Unknown 2 |
Follow Lip Diseases: new trials by email Literature Review of Lip Diseases trials Research Report on Lip Diseases
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Liposomal Bupivacaine Use in Alveolar Bone Graft Patients Liposomal Bupivacaine, Bupivacain, Epinephrine - Cleft Lip and Palate | Phase 3 | Unknown | Kerry O'Rourke | 60 | 2024-04-24 | 2024-07-03 |
| NB-001 Treatment of Recurrent Herpes Labialis NB-001 (0.3%), Placebo - Herpes Labialis | Phase 3 | Unknown | NanoBio Corporation | 362 | 2012-10-01 | 2013-06-14 |
Agnosia (1) · Cleft Lip (1) · Cleft Palate (1) · Herpes Labialis (1) · Herpes Simplex (1)
Mouth Diseases (2) · Stomatognathic Diseases (2) · Congenital Abnormalities (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Craniofacial Abnormalities (1) · DNA Virus Infections (1) · Herpesviridae Infections (1) · Infections (1) · Jaw Abnormalities (1) · Jaw Diseases (1) · Maxillofacial Abnormalities (1) · Mouth Abnormalities (1) · Musculoskeletal Abnormalities (1) · Musculoskeletal Diseases (1)
5-((2-(6-Amino-9H-purin-9-yl) ethyl) amino)-1-pentanol (1) · Bupivacaine (1) · Epinephrine (1)
Kerry O'Rourke (1) · NanoBio Corporation (1)
United States (2)